Thalidomide for managing cancer cachexia
Data up to Jan 2025
Total Citations Per Year
Abstract
References (63)
Measuring inconsistency in meta-analyses
2003 • 53,662 citations
Meta-analysis in clinical trials
1986 • 36,193 citations
Cochrane Handbook for Systematic Reviews of Interventions
2008 • 18,785 citations
Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration
2013 • 5,537 citations
Definition and classification of cancer cachexia: an international consensus
2011 • 4,715 citations
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints
1998 • 4,679 citations
The clinical evaluation of chemotherapeutic agents in cancer
1949 • 2,793 citations
Meta-analysis: Principles and procedures
1997 • 2,277 citations
Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”
2010 • 1,587 citations
Systematic Reviews in Health Care. Meta-analysis in Context.
2002 • 1,441 citations
Mechanisms of Cancer Cachexia
2009 • 1,102 citations
Cachexia in cancer patients
2002 • 953 citations
Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis
2006 • 744 citations
Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial
2003 • 590 citations
Cancer Anorexia-Cachexia Syndrome: Current Issues in Research and Management
2002 • 579 citations
Cancer cachexia: Developing multimodal therapy for a multidimensional problem
2008 • 428 citations
Evaluation of Chemotherapeutic Agents.
1950 • 393 citations
Cachexia
2000 • 378 citations
Further validation of the multidimensional fatigue symptom inventory-short form
2004 • 345 citations
Cancer anorexia-cachexia syndrome: are neuropeptides the key?
1999 • 345 citations
Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial
2005 • 312 citations
Therapy Insight: cancer anorexia–cachexia syndrome—when all you can eat is yourself
2005 • 310 citations
Muscle Wasting in Cancer Cachexia: Clinical Implications, Diagnosis, and Emerging Treatment Strategies
2010 • 309 citations
Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia
2007 • 257 citations
Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.
1993 • 227 citations
Megestrol acetate for treatment of anorexia-cachexia syndrome
2005 • 206 citations
Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia
2010 • 206 citations
Cancer anorexia-cachexia syndrome: cytokines and neuropeptides
2004 • 190 citations
Thalidomide in patients with cachexia due to terminal cancer: Preliminary report
1999 • 128 citations
The experience of cancer cachexia: A qualitative study of advanced cancer patients and their family members
2008 • 125 citations
Anticytokine approaches to the treatment of anorexia and cachexia.
1998 • 101 citations
Oesophageal cancer and cachexia: the effect of short‐term treatment with thalidomide on weight loss and lean body mass
2003 • 97 citations
Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results
2008 • 97 citations
Fighting Over Food: Patient and Family Understanding of Cancer Cachexia
2009 • 80 citations
Palliative Medicine: A Case-Based Manual
2021 • 69 citations
Randomized Double-Blind Placebo-Controlled Trial of Thalidomide in Combination With Gemcitabine and Carboplatin in Advanced Non–Small-Cell Lung Cancer
2009 • 67 citations
The Cancer Anorexia–Cachexia Syndrome
2002 • 65 citations
Topics in Palliative Care
1997 • 63 citations
Physical activity level as an outcome measure for use in cancer cachexia trials: a feasibility study
2009 • 63 citations
PHASE II STUDY OF PACLITAXEL AND CISPLATIN FOR ADVANCED UROTHELIAL CANCER
2000 • 61 citations
Primary caregiver perceptions of intake cessation in patients who are terminally Ill.
1997 • 59 citations
Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: Phase I clinical trial of three dosing schedules in patients with solid malignancies
2006 • 51 citations
Time‐Dependent Variation in Weight and Body Composition in Healthy Adults
2000 • 50 citations
Research methodology: cancer cachexia syndrome
2004 • 49 citations
The Pathophysiology and Treatment of Cancer Cachexia
2002 • 48 citations
Update on emerging drugs for cancer cachexia
2009 • 46 citations
Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia.
2010 • 44 citations
Thalidomide: a new anticancer drug?
2003 • 38 citations
Poor tolerability of thalidomide in end-stage oesophageal cancer
2011 • 33 citations
Cancer cachexia therapy: a key weapon in the fight against cancer
2011 • 27 citations
Incidence and Costs of Acute Medical Conditions in Long-Stay Incontinent Nursing Home Residents
2003 • 19 citations
Low tolerance and high toxicity of thalidomide as maintenance therapy after double autologous stem cell transplant in multiple myeloma patients
2006 • 16 citations
On the Natural Laws of Muscular Exertion
1870 • 13 citations
Thalidomide and cancer cachexia: old problem, new hope?
2005 • 12 citations
Thalidomide in the Treatment of Cancer Cachexia
2008 • 11 citations
Palliative care from the beginning of treatment for advanced pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
2010 • 6 citations
The problem of weakness in patients with advanced cancer
1999 • 6 citations
Thalidomide Celgene Corp.
1998 • 4 citations
Adiponectin and insulin resistance associated with endometrial cancer
2006 • 3 citations
Nuevos fármacos potencialmente útiles para el tratamiento de la caquexia en cuidados paliativos
2001 • 2 citations
67 Malignant mesothelioma (MM) and cachexia. Description of body composition changes in 27 patients receiving chemotherapy and/or thalidomide treatment
2006 • 1 citations
Thalidomide: an effective anabolic agent in gastrointestinal cancer cachexia: authors’ reply
2006 • 1 citations
Gemcitabine (G) and Doxorubicin (DXR) as first-line treatment of metastatic breast cancer (MBC): Preliminary results
2004 • 1 citations